Molnlycke Health Care Expands Wound Care Manufacturing Facility
Summary: Molnlycke Health Care is investing $135 million to expand its Brunswick, Maine facility, increasing U.S. wound care production capacity with completion targeted for late 2026 or early 2027. The upgrade features advanced U.S.-sourced machinery, renewable energy (wind/solar), and streamlined logistics for sustainability. Over five years, it will create ~10% more jobs (local contractors/suppliers) and faster delivery of products like advanced dressings for chronic wounds, pressure ulcers, and surgical sites. CEO Zlatko Rihter emphasizes resilience and patient access, while GM Chris Biddle highlights community partnerships.
Key Highlights:
- Investment scope: $135M for expansion; boosts production of wound care solutions amid rising demand.
- Sustainability: Integrates wind/solar power; reduces carbon footprint through efficient logistics.
- Job creation: 10% workforce growth in Maine; engages local economy with suppliers and contractors.
- Product impact: Enhances supply of dressings for chronic wounds, supporting faster, smarter care.
- Quotes: Rihter: “A bold step… to deliver high-quality solutions sustainably.” Biddle: “A win for Molnlycke, community, and patients.”
Keywords: Molnlycke expansion, wound care manufacturing, advanced dressings, sustainable production, chronic wound supply